MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, İsmail Can et al.|Cancer Cell|2017Cited by 607
The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune MicroenvironmentGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Immunity|2018Cited by 216
Mutation based approaches to the treatment of anaplastic thyroid cancerHilary C. McCrary, Dev Abraham, Joni Aoki et al.|Clinical Endocrinology|2022Cited by 26
Sox2 cooperates with Lkb1 loss to promote squamous cell lung cancerAnandaroop Mukhopadhyay, Trudy G. Oliver, Gürkan Mollaoglu et al.|Journal of Thoracic Oncology|2016Cited by 0
Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancerGürkan Mollaoglu, Trudy G. Oliver, Alex Jones et al.|Cancer Immunology Research|2020Cited by 0